Access the full text.
Sign up today, get DeepDyve free for 14 days.
Guo-he Song, Shifeng Xu, Hong Zhang, Yupeng Wang, Chao Xiao, T. Jiang, Leilei Wu, Zhang Tao, Xing Sun, L. Zhong, Chongzhi Zhou, Zhaowen Wang, Zhihai Peng, Jian Chen, Xiaoliang Wang (2016)TIMP1 is a prognostic marker for the progression and metastasis of colon cancer through FAK-PI3K/AKT and MAPK pathway
Journal of Experimental & Clinical Cancer Research : CR, 35
Steinacker J Prokopchuk O (2016)Prokopchuk O, Steinacker J, Nitsche U, Otto S, Bachmann J, Schubert E, et al. IL-4 mRNA is downregulated in the liver of pancreatic cancer patients suffering from cachexia. Nutr Cancer. 2016;69 in press
K. Goonetilleke, A. Siriwardena (2007)Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 33 3
T. Gress, F. Müller‐Pillasch, M. Lerch, H. Friess, M. Büchler, G. Adler (1995)Expression and in‐situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer
International Journal of Cancer, 62
Bastian Seubert, Barbara Grünwald, Julia Kobuch, Haissi Cui, F. Schelter, Susanne Schaten, J. Siveke, N. Lim, H. Nagase, Nicole Simonavicius, M. Heikenwalder, T. Reinheckel, J. Sleeman, K. Janssen, P. Knolle, A. Krüger (2015)Tissue inhibitor of metalloproteinases (TIMP)‐1 creates a premetastatic niche in the liver through SDF‐1/CXCR4‐dependent neutrophil recruitment in mice
Zhao-Shi Zeng, A. Cohen, Zuo‐Feng Zhang, W. Stetler-Stevenson, J. Guillem (1995)Elevated tissue inhibitor of metalloproteinase 1 RNA in colorectal cancer stroma correlates with lymph node and distant metastases.
Clinical cancer research : an official journal of the American Association for Cancer Research, 1 8
V Elliott C Jenkinson (2015)Evaluation in pre-diagnosis samples discounts ICAM-1 and TIMP-1 as biomarkers for earlier diagnosis of pancreatic cancer
J Proteome, 113
G. Cheng, Xuemei Fan, M. Hao, Jinglong Wang, Xiaoming Zhou, Xueqing Sun (2016)Higher levels of TIMP-1 expression are associated with a poor prognosis in triple-negative breast cancer
Molecular Cancer, 15
Barbara Grünwald, V. Harant, Susanne Schaten, Monika Frühschütz, Ria Spallek, B. Höchst, Katharina Stutzer, S. Berchtold, M. Erkan, O. Prokopchuk, M. Martignoni, I. Esposito, M. Heikenwalder, Aayush Gupta, J. Siveke, P. Saftig, P. Knolle, D. Wohlleber, A. Krüger (2016)Pancreatic Premalignant Lesions Secrete Tissue Inhibitor of Metalloproteinases-1, Which Activates Hepatic Stellate Cells Via CD63 Signaling to Create a Premetastatic Niche in the Liver.
Gastroenterology, 151 5
M. Holten-Andersen, R. Stephens, H. Nielsen, G. Murphy, I. Christensen, W. Stetler-Stevenson, N. Brünner (2000)High preoperative plasma tissue inhibitor of metalloproteinase-1 levels are associated with short survival of patients with colorectal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research, 6 11
Aline Toneto, Luiz Ramos, E. Salomão, R. Tomasin, Miguel Aereas, M. Gomes-Marcondes (2016)Nutritional leucine supplementation attenuates cardiac failure in tumour‐bearing cachectic animals
Journal of Cachexia, Sarcopenia and Muscle, 7
Sheng Pan, Ru Chen, R. Brand, S. Hawley, Y. Tamura, Philip Gafken, Brian Milless, D. Goodlett, J. Rush, T. Brentnall (2012)Multiplex targeted proteomic assay for biomarker detection in plasma: a pancreatic cancer biomarker case study.
Journal of proteome research, 11 3
A. Skorokhod, Jeannine Bachmann, N. Giese, M. Martignoni, Holger Krakowski-Roosen (2012)Real-imaging cDNA-AFLP transcript profiling of pancreatic cancer patients: Egr-1 as a potential key regulator of muscle cachexia
BMC Cancer, 12
C. Jenkinson, V. Elliott, U. Menon, S. Apostolidou, O. Fourkala, A. Gentry-Maharaj, S. Pereira, S. Pereira, I. Jacobs, I. Jacobs, T. Cox, W. Greenhalf, J. Timms, R. Sutton, J. Neoptolemos, Eithne Costello (2015)Evaluation in pre-diagnosis samples discounts ICAM-1 and TIMP-1 as biomarkers for earlier diagnosis of pancreatic cancer.
Journal of proteomics, 113
J. Springer, Anika Tschirner, A. Haghikia, S. Haehling, Hind Lal, A. Grzesiak, E. Kaschina, Sandra Palus, Mareike Pötsch, K. Websky, B. Hocher, Céline Latouche, F. Jaisser, L. Morawietz, A. Coats, J. Beadle, J. Argilés, T. Thum, G. Földes, W. Doehner, D. Hilfiker-Kleiner, T. Force, S. Anker (2014)Prevention of liver cancer cachexia-induced cardiac wasting and heart failure.
European heart journal, 35 14
S. Cascinu, M. Falconi, V. Valentini, S. Jelić (2010)Pancreatic cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Annals of oncology : official journal of the European Society for Medical Oncology, 21 Suppl 5
B. Mroczko, Marta Lukaszewicz-Zajac, U. Wereszczyńska-Siemiątkowska, Magdalena Groblewska, M. Gryko, B. Kędra, G. Jurkowska, M. Szmitkowski (2009)Clinical Significance of the Measurements of Serum Matrix Metalloproteinase-9 and Its Inhibitor (Tissue Inhibitor of Metalloproteinase-1) in Patients With Pancreatic Cancer: Metalloproteinase-9 as an Independent Prognostic Factor
Y. Gong, G.M. Xu, W. Huang, L.B. Chen (2000)Expression of matrix metalloproteinases and the tissue inhibitors of metalloproteinases and their local invasiveness and metastasis in Chinese human pancreatic cancer
Journal of Surgical Oncology, 73
Harant V Grunwald B (2016)151(5):1011-24
Haissi Cui, Bastian Seubert, Evi Stahl, Hendrik Dietz, U. Reuning, L. Moreno-Leon, M. Ilié, P. Hofman, H. Nagase, B. Mari, A. Krüger (2014)Tissue inhibitor of metalloproteinases-1 induces a pro-tumourigenic increase of miR-210 in lung adenocarcinoma cells and their exosomes
M. Jøergensen, N. Brünner, O. Muckadell (2010)Comparison of circulating MMP-9, TIMP-1 and CA19-9 in the detection of pancreatic cancer.
Anticancer research, 30 2
T. Yoshikawa, Haruhiko Cho, A. Tsuburaya, O. Kobayashi (2009)Impact of plasma tissue inhibitor of metalloproteinase-1 on long-term survival in patients with gastric cancer
Gastric Cancer, 12
S. Würtz, S. Møller, H. Mouridsen, P. Hertel, E. Friis, N. Brünner (2008)Plasma and Serum Levels of Tissue Inhibitor of Metalloproteinases-1 Are Associated with Prognosis in Node-negative Breast Cancer
Molecular & Cellular Proteomics, 7
K. Poruk, M. Firpo, C. Scaife, D. Adler, L. Emerson, K. Boucher, S. Mulvihill (2013)Serum Osteopontin and Tissue Inhibitor of Metalloproteinase 1 as Diagnostic and Prognostic Biomarkers for Pancreatic Adenocarcinoma
MW Buchler W Hartwig (2013)Pancreatic cancer: current options for diagnosis, staging and therapeutic management
Gastrointest Tumors, 1
Hong Zhang, B. Liu, Xiao-fan Xu, Ting-Ting Jiang, Xiao-qin Zhang, Ying-Li Shi, Yu Chen, Fang Liu, Jie Gu, Lin-jia Zhu, N. Wu (2016)Pathophysiology of chronic pancreatitis induced by dibutyltin dichloride joint ethanol in mice.
World journal of gastroenterology, 22 10
O. Prokopchuk, J. Steinacker, U. Nitsche, S. Otto, Jeannine Bachmann, E. Schubert, H. Friess, M. Martignoni (2017)IL-4 mRNA Is Downregulated in the Liver of Pancreatic Cancer Patients Suffering from Cachexia
Nutrition and Cancer, 69
H. An, Yoon-Jin Lee, S. Hong, Jeong-Oh Kim, Kyounbun Lee, Y. Kim, J. Park, Jin-Hyoung Kang (2016)The prognostic role of tissue and serum MMP-1 and TIMP-1 expression in patients with non-small cell lung cancer.
Pathology, research and practice, 212 5
R. Devine, S. Bicer, P. Reiser, M. Velten, L. Wold (2015)Metalloproteinase expression is altered in cardiac and skeletal muscle in cancer cachexia.
American journal of physiology. Heart and circulatory physiology, 309 4
J. Argiles, F. López‐Soriano, Míriam Toledo, Angélica Betancourt, R. Serpe, S. Busquets (2011)The cachexia score (CASCO): a new tool for staging cachectic cancer patients
Journal of Cachexia, Sarcopenia and Muscle, 2
Haissi Cui, S. Grosso, F. Schelter, B. Mari, A. Krüger (2012)On the Pro-Metastatic Stress Response to Cancer Therapies: Evidence for a Positive Co-Operation between TIMP-1, HIF-1α, and miR-210
Frontiers in Pharmacology, 3
Ferreira Ramos LA Toneto AT (2016)7(5):577-86
T. Hothorn, A. Zeileis (2008)Generalized Maximally Selected Statistics
Jeannine Bachmann, M. Büchler, H. Friess, M. Martignoni (2013)Cachexia in Patients with Chronic Pancreatitis and Pancreatic Cancer: Impact on Survival and Outcome
Nutrition and Cancer, 65
A. Krüger (2015)Premetastatic niche formation in the liver: emerging mechanisms and mouse models
Journal of Molecular Medicine, 93
W. Alpízar-Alpízar, O. Laerum, I. Christensen, K. Ovrebo, A. Skarstein, G. Høyer-Hansen, M. Ploug, M. Illemann (2016)Tissue Inhibitor of Metalloproteinase-1 Is Confined to Tumor-Associated Myofibroblasts and Is Increased With Progression in Gastric Adenocarcinoma
Journal of Histochemistry & Cytochemistry, 64
S. Schwarz, O. Prokopchuk, K. Esefeld, S. Gröschel, Jeannine Bachmann, Sylvie Lorenzen, Helmut Friess, Martin Halle, Marc Martignoni (2017)The clinical picture of cachexia: a mosaic of different parameters (experience of 503 patients)
BMC Cancer, 17
Sheng Pan, Ru Chen, D. Crispin, Damon May, T. Stevens, M. McIntosh, M. Bronner, A. Ziogas, H. Anton-Culver, T. Brentnall (2011)Protein alterations associated with pancreatic cancer and chronic pancreatitis found in human plasma using global quantitative proteomics profiling.
Journal of proteome research, 10 5
K. Fearon, F. Strasser, S. Anker, I. Bosaeus, E. Bruera, R. Fainsinger, A. Jatoi, C. Loprinzi, N. Macdonald, G. Mantovani, Mellar Davis, M. Muscaritoli, F. Ottery, L. Radbruch, P. Ravasco, D. Walsh, A. Wilcock, S. Kaasa, V. Baracos (2011)Definition and classification of cancer cachexia: an international consensus.
The Lancet. Oncology, 12 5
Jeannine Bachmann, Mathias Heiligensetzer, Holger Krakowski-Roosen, M. Büchler, H. Friess, M. Martignoni (2008)Cachexia Worsens Prognosis in Patients with Resectable Pancreatic Cancer
Journal of Gastrointestinal Surgery, 12
M. Martignoni, C. Dimitriu, J. Bachmann, Holger Krakowski-Rosen, K. Ketterer, R. Kinscherf, H. Friess (2009)Liver macrophages contribute to pancreatic cancer-related cachexia.
Oncology reports, 21 2
S Moller SO Wurtz (2008)Plasma and serum levels of tissue inhibitor of metalloproteinases-1 are associated with prognosis in node-negative breast cancer: a prospective study
Mol Cell Proteomics, 7
W. Hartwig, M. BüchlerMini-review Pancreatic Cancer: Current Options for Diagnosis, Staging and Therapeutic Management
M. Kozłowski, W. Laudański, B. Mroczko, M. Szmitkowski, R. Milewski, Grzegorz Łapuć (2013)Serum tissue inhibitor of metalloproteinase 1 (TIMP-1) and vascular endothelial growth factor A (VEGF-A) are associated with prognosis in esophageal cancer patients.
Advances in medical sciences, 58 2
Jeannine Bachmann, K. Ketterer, C. Marsch, K. Fechtner, Holger Krakowski-Roosen, M. Büchler, H. Friess, M. Martignoni (2009)Pancreatic cancerrelated cachexia: influence on metabolism and correlation to weight loss and pulmonary function
BMC Cancer, 9
DV Mann, R. Edwards, S. Ho, WY Lau, G. Glazer (2000)Elevated tumour marker CA19-9: clinical interpretation and influence of obstructive jaundice.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 26 5
Abstract Background Tissue inhibitor of metalloproteinases-1 (TIMP-1) is a candidate diagnostic and prognostic biomarker for pancreatic ductal adenocarcinoma (PDAC). Here, we determined the possible association of systemic TIMP-1 levels with cachexia and jaundice, two common PDAC-associated conditions. Methods Plasma TIMP-1 was measured by ELISA in patients diagnosed with PDAC (n = 36) and chronic pancreatitis (CP) (n = 25). Patients without pancreatic pathologies and known malignancies of other origin served as controls (n = 13). TIMP-1 levels in these patients were tested for asscociation with jaundice and chachexia, and furthermore correlated with cachexia-related clinical parameters such as weight loss and ferritin, parameters of lung function, hemoglobin and liver synthesis parameters. Results TIMP-1 plasma levels were mostly higher in CP and PDAC patients with concomitant jaundice or cachexia. Elevated plasma TIMP-1 levels were also associated with clinical cachexia markers, including absolute and relative values of weight loss and lung function, as well as ferritin, hemoglobin, and cholinesterase levels. TIMP-1 levels significantly correlated with cachexia only in patients without jaundice. Jaundice also impaired the use of TIMP-1 as a prognostic marker in cancer patients. Relating to cachexia status alone, a slightly improved association of TIMP-1 levels with survival of PDAC patients was observed. Conclusion This retrospective study reports for the first time that plasma levels of TIMP-1 are associated with pancreatic lesion-induced cachexia in patients without jaundice. TIMP-1 is counterindicated as a survival marker in patients with jaundice.
BMC Cancer – Springer Journals
Published: Dec 1, 2018
Keywords: cancer research; oncology; surgical oncology; health promotion and disease prevention; biomedicine, general; medicine/public health, general
Access the full text.
Sign up today, get DeepDyve free for 14 days.